FDA Inspection 1240192 — Natasha E. Ballard, M.D.
The FDA completed an inspection of Natasha E. Ballard, M.D. on May 21, 2024 in Chattanooga, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 21, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Chattanooga, TN (United States)
Additional Details
Clinical Investigator (CI)